CIMT 15th Anniversary Symposium

May 10-11, 2017

The 15th meeting of the Association for Cancer Immunotherapy is an anniversary members symposium that will celebrate the work of cancer immunotherapy research through scientific presentations and a special awards dinner. The symposium will bring together leading international experts on adoptive cell theapy, cancer epigenetics, antibodies, cancer vaccination and immunoguiding. They will present an overview of past and present developments and will discuss clinical and translational developments.


Day 1

10:00 - 17:30
Frankfurter Hof - Foyer


and badge pickup

12:00 - 15:00
Frankfurter Hof

CIP Immunoguiding Seminar

"Immune Assessment"

12:00 - 12:30

Sven Brandau, University Hospital Essen
"Neutrophils and MDSC in cancer: Immunomonitoring and clinical relevance"

12:30 - 13:00

Xavier Romero Ros, Amsterdam Medical Center
"Innate lymphoid cells as novel therapeutic targets in disease "

13:00 - 13:45

Lunch, food and beverages
at Frankfurter Hof

13:45 - 14:00

CIP Steering Committee, Marij Welters, Sine Reker Hadrup
"CIP activities summary: ongoing projects and planned activities"

14:00 - 14:30

Tanja de Gruijl, VU University Medical Center Amsterdam
“Phenotypic and functional immune profiling of sentinel lymph nodes: clues for early clinical intervention”

14:30 - 15:00

Angela M. Krackhardt, Technical University Munich
"Immunopeptidomics & T-cell trafficking"

16:00 - 17:00
Erbacher Hof

CMT Members Meeting

General Members Assembly of the Asscociation for Cancer Immunotherapy

17:30 - 18:00
Frankfurter Hof

Welcome Address

Christoph Huber CIMT

18:00 - 19:00
Frankfurter Hof

Keynote Lecture

Alexander Eggermont
Institut Gustave Roussy

“Immune-checkpoint inhibitors from advanced disease to the adjuvant setting”

19:00 - 22:00
Frankfurter Hof

Lifetime Achievement Award Ceremony and Reception

Speeches, drinks and food

Day 2

08:30 - 10:00
Frankfurter Hof

Session 1

Clinical Translation, Cancer Vaccination

Chairs: TBA

08:30 - 09:00

Christian Ottensmeier, University of Southampton
"Clinical Translation of Immunotherapy. Where do we stand?"

09:00 - 09:30

Carl Figdor, Radboud University
"Synthetic dendritic cells as 21st century cancer vaccines"

09:30 - 10:00

Ugur Sahin, BioNTech
"mRNA based cancer immunotherapy"

10:00 - 10:30

Coffee Break

Coffee and snacks

10:30 - 12:00
Frankfurter Hof

Session 2

Adoptive T-Cell Therapy, Innate Immunity, Cancer Epigenetics

Chairs: TBA

10:30 - 11:00

Johanna Olweus, Oslo University Hospital Radiumhospitalet/Jebsen Center for Cancer Immunotherapy
"Adoptive T cell therapy - the quest for anti-tumor missiles"

11:00 - 11:30

Eric Vivier, Centre d'Immunologie de Marseille-Luminy
"Innate immunity in cancer immunotherapy – status & perspectives"

11:30 - 12:00

Manel Esteller Badosa, University of Barcelona
"Cancer epigenetics: From knowledge to applications"

12:00 - 13:30


food and drinks

13:30 - 15:00
Frankfurter Hof

Session 3

Antibodies, Helper T-Cell Physiology

Chairs: TBA

13:30 - 14:00

Özlem Türeci, Ci3-Cluster for Individualized Immune Intervention
"Antibody based cancer therapy"

14:00 - 14:30

Vincenzo Cerundolo, University of Oxford
"Amino acid degrading enzymes and their role in tumour immune escape mechanisms"

14:30 - 15:00

Olivier Lantz, Institut Curie
"CD4 T cells in anti-tumor immunity"

15:00 - 15:30

Coffee Break

Coffee and snacks

15:30 - 17:00
Frankfurter Hof

Session 4

HLA Ligandome, Clinical Immunomonitoring

Chairs: TBA

14:30 - 15:00

Stefan Stevanovic, University of Tübingen
"Cancer HLA ligandome and multiepitope vaccination"

15:00 - 15:30

Patrick Hwu, MD Anderson Cancer Center
"The interplay between tumor biology and the antitumor immune response"

15:30 - 16:00

Marij Welters, Leiden University Medical Center
"Clinical Immunomonitoring. Progress and relevance"